Regenxbio (RGNX) Tax Provisions (2018 - 2022)
Regenxbio (RGNX) posted quarterly Tax Provisions of -$58.8 million for Q4 2022, down 539.04% year-over-year from $13.4 million in Q4 2021, and down 143421.95% quarter-over-quarter from -$41000.0 in Q1 2022.
Regenxbio (RGNX) Tax Provisions (2018 - 2022) Analysis & Trends
Regenxbio's Tax Provisions history runs 5 years deep, the most recent figure standing at -$58.8 million for Q4 2022.
- In Q4 2022, Tax Provisions fell 539.04% year-over-year to -$58.8 million; the TTM figure through Dec 2022 stood at -$58.9 million (down 539.21% YoY), while the FY2024 annual figure was $3.5 million, up 2404.61% from the prior year.
- Tax Provisions for Q4 2022 stood at -$58.8 million, down from -$41000.0 in the prior quarter.
- The five-year high for Tax Provisions was $13.4 million in Q4 2021, with the low at -$58.8 million in Q4 2022.
- The 5-year median for Tax Provisions is -$22000.0 (2020), against an average of -$4.0 million.
- The sharpest annual moves came in 2019 and 2021: Tax Provisions sank 1340.53% in 2019, then jumped 133.38% in 2021.
- Regenxbio's Tax Provisions stood at $1.6 million in 2018, then tumbled by 1340.53% to -$20.1 million in 2019, then surged by 128.56% to $5.7 million in 2020, then soared by 133.38% to $13.4 million in 2021, then slumped by 539.04% to -$58.8 million in 2022.
- Business Quant data shows RGNX's Tax Provisions at -$58.8 million in Q4 2022, -$41000.0 in Q1 2022, and $13.4 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -58.84 Mn |
| Mar 31, 2022 | -41,000.00 |
| Dec 31, 2021 | 13.40 Mn |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 5.74 Mn |
| Sep 30, 2020 | -3,000.00 |
| Jun 30, 2020 | -500,000.00 |
| Dec 31, 2019 | -20.11 Mn |
| Sep 30, 2019 | -165,000.00 |
| Jun 30, 2019 | -129,000.00 |
| Mar 31, 2019 | 70,000.00 |
| Dec 31, 2018 | 1.62 Mn |
| Sep 30, 2018 | -1.29 Mn |
| Jun 30, 2018 | 3.85 Mn |